Literature DB >> 18980543

Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development.

Silvia Baroncelli1, Donatella R M Negri, Zuleika Michelini, Andrea Cara.   

Abstract

Over the past 20 years, many efforts have been made to develop a vaccine against AIDS. The lack of an animal model that can be productively infected with HIV-1 has been partially replaced by macaque species infected with SIV or chimeric SHIV. Natural SIV and chimeric SHIV cause an infection resembling human AIDS, and Asian monkeys of genus Macaca (species mulatta, fascicularis and nemestrina) should be considered a useful surrogate in vaccine trials. A multitude of vaccines and immunization approaches have been evaluated, including live-attenuated viruses, DNA vaccines, subunit proteins and viral and bacterial vectors. The results of all these studies are often difficult to interpret due to lack of standardizations, choice of challenging virus and differences in the macaque species used. This article aims at summarizing the main characteristics of the three macaque species used in vaccine trials.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18980543     DOI: 10.1586/14760584.7.9.1419

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  25 in total

1.  Robust suppression of env-SHIV viremia in Macaca nemestrina by 3-drug ART is independent of timing of initiation during chronic infection.

Authors:  Christopher W Peterson; Patrick Younan; Patricia S Polacino; Nicholas J Maurice; Hannah W Miller; Martin Prlic; Keith R Jerome; Ann E Woolfrey; Shiu-Lok Hu; Hans-Peter Kiem
Journal:  J Med Primatol       Date:  2013-10       Impact factor: 0.667

Review 2.  Improving genome assemblies and annotations for nonhuman primates.

Authors:  Robert B Norgren
Journal:  ILAR J       Date:  2013

3.  A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae.

Authors:  Philippe Denoël; Mario T Philipp; Lara Doyle; Dale Martin; Georges Carletti; Jan T Poolman
Journal:  Vaccine       Date:  2011-05-30       Impact factor: 3.641

4.  Comparative analysis of NK-cell receptor expression and function across primate species: Perspective on antiviral defenses.

Authors:  Roberto Biassoni; Elisabetta Ugolotti; Andrea De Maria
Journal:  Self Nonself       Date:  2010-03-06

5.  Replication potentials of HIV-1/HSIV in PBMCs from northern pig-tailed macaque (Macaca leonina).

Authors:  Ai-Hua Lei; Gao-Hong Zhang; Ren-Rong Tian; Jia-Wu Zhu; Hong-Yi Zheng; Wei Pang; Yong-Tang Zheng
Journal:  Dongwuxue Yanjiu       Date:  2014-05

6.  Cynomolgus and pigtail macaque IgG subclasses: characterization of IGHG genes and computational analysis of IgG/Fc receptor binding affinity.

Authors:  Doan C Nguyen; Rashesh Sanghvi; Franco Scinicariello; Joanna Pulit-Penaloza; Nicole Hill; Roberta Attanasio
Journal:  Immunogenetics       Date:  2014-05-09       Impact factor: 2.846

7.  Efficient mucosal transmissibility but limited pathogenicity of R5 SHIV SF162P3N in Chinese-origin rhesus macaques.

Authors:  Alexandra Mumbauer; Agegenhu Gettie; James Blanchard; Cecilia Cheng-Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-15       Impact factor: 3.731

8.  Identification of novel MHC class I sequences in pig-tailed macaques by amplicon pyrosequencing and full-length cDNA cloning and sequencing.

Authors:  Claire E O'Leary; Roger W Wiseman; Julie A Karl; Benjamin N Bimber; Simon M Lank; Jennifer J Tuscher; David H O'Connor
Journal:  Immunogenetics       Date:  2009-09-24       Impact factor: 2.846

9.  Spontaneous cervicovaginal lesions and immune cell infiltrates in nonhuman primates.

Authors:  Carole E Harbison; Mary E Ellis; Susan V Westmoreland
Journal:  Toxicol Pathol       Date:  2013-02-20       Impact factor: 1.902

10.  Lentiviral vector-based prime/boost vaccination against AIDS: pilot study shows protection against Simian immunodeficiency virus SIVmac251 challenge in macaques.

Authors:  Anne-Sophie Beignon; Karine Mollier; Christelle Liard; Frédéric Coutant; Sandie Munier; Julie Rivière; Philippe Souque; Pierre Charneau
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.